Here are three highlights:
1. The patent covers “administering any spine deformation therapeutics to a patient having a spine deformation altered risk associated biomarker.”
2. This patent supports the company’s commercial use of their diagnostic and next-generation companion treatment products.
3. Predictive Technology Group currently has pending U.S. and international patent applications.
More articles on devices:
Coastal Orthopedics’ Dr. Gennady Gekht is 1st west coast Florida physician to use the Axium Neurostimulator System: 4 notes
Life Spine announces initial cases and multiple surgeries for LONGBOW™ Expandable Lateral Spacer System
FDA clears Spinal Elements’ line of expandable interbody devices: 5 notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
